Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 06, 2017 08:00 ET | Source: Integrated Diagnostics

Indi(R) Secures $6.1 Million in Financing and Major Medicare Coverage Milestone for Xpresys(R) Lung Molecular Diagnostic For Ruling Out Lung Cancer

SEATTLE, WA--(Marketwired - January 06, 2017) - Indi (Integrated Diagnostics®) today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) and national Medicare MolDx program...
June 22, 2015 12:24 ET | Source: Integrated Diagnostics

Widespread Overtreatment of Benign Lung Nodules Seen in Landmark Chart Review Study

SEATTLE, WA--(Marketwired - Jun 22, 2015) - Indi (Integrated Diagnostics®) today announced CHEST has published a landmark chart review study, suggesting widespread overtreatment of benign lung...
March 17, 2015 17:00 ET | Source: Integrated Diagnostics

Indi(R) Publishes Technical Paper on Methods to Improve Reproducibility and Robustness of MRM-Mass Spec Proteomic Tests

SEATTLE, WA--(Marketwired - Mar 17, 2015) - Indi (Integrated Diagnostics®) today announced publication of a technical paper in Clinical Proteomics providing details about the assay variability...
February 03, 2015 09:30 ET | Source: Integrated Diagnostics

Indi(R) Announces Agreement to License Xpresys(R) Lung in Canada to Caprion

SEATTLE, WA--(Marketwired - Feb 3, 2015) - Indi (Integrated Diagnostics®) today announced an exclusive agreement to license Xpresys Lung in Canada to Caprion. Xpresys Lung is Indi's...
January 29, 2015 07:30 ET | Source: Integrated Diagnostics

Landmark Indi(R) Publication Shows Xpresys(R) Lung Helps Identify Benign Lung Nodules

SEATTLE, WA--(Marketwired - Jan 29, 2015) - Indi (Integrated Diagnostics®) today announced that the Journal of Thoracic Oncology (JTO) has published positive results from a landmark clinical...
January 08, 2015 07:30 ET | Source: Integrated Diagnostics

Indi(R) Appoints Douglas Sanders CFO

SEATTLE, WA--(Marketwired - Jan 8, 2015) - Indi (Integrated Diagnostics®), a molecular diagnostics company pioneering the use of blood-based proteomic tests, today announced that it has...
December 17, 2014 07:30 ET | Source: Indi Molecular

Indi Molecular(R) and Sigma-Aldrich(R) Establish Collaboration to Explore Use of PCC Technology in Biological Tools

CULVER CITY, CA--(Marketwired - Dec 17, 2014) - Indi Molecular, the maker of a synthetic replacement for monoclonal antibodies, today announced that it has entered into a co-development agreement...
November 05, 2014 08:30 ET | Source: Integrated Diagnostics

Indi(R) Secures Contracts for Xpresys(R) Lung With Multiplan and Five Other PPOs; Blood Test for Pulmonary Nodules Now Available to 200 Million Covered Lives

SEATTLE, WA--(Marketwired - Nov 5, 2014) - Indi® (Integrated Diagnostics), an emerging leader in molecular diagnostics, today announced that the company has secured contractual agreements with...
April 29, 2014 07:30 ET | Source: Integrated Diagnostics

Indi(R) Announces $47.25 Million in Funding for Blockbuster Diagnostic

SEATTLE, WA--(Marketwired - Apr 29, 2014) - Indi® (Integrated Diagnostics), a molecular diagnostics company pioneering the use of blood-based proteomic tests, announced today it has raised...
December 10, 2013 07:01 ET | Source: Integrated Diagnostics

Indi Molecular Expands Seed Round to $1.8 Million With Additional $300K From Asset Management Ventures

CULVER CITY, CA--(Marketwired - Dec 10, 2013) - Indi Molecular, which pioneered a synthetic replacement for antibodies, today announced that it has raised an additional $300,000 from a new investor,...